| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e47689043796b95c37afa314678a1dba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4af6075a1576ecfe0db9a02dbd19a50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_625bbabbd3001103baead2545e8c147d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_558f0f2d03cc9f2aa00019bce75c6493
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b66b86852b9a10dfa413d7b0188704cf |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-57563 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-77 |
| filingDate |
2018-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eca653a6cc284a4ba3fc4360fd7b11c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb8c01743a1d7e6c7ea78ad5bab6bec4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_519f13500f0c1e432ab56e9ced7efba2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54366538f9b88d56c1214b9b896e18d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f999ce4ca44e5aa0a10ef87e64398d2c |
| publicationDate |
2020-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2020339661-A1 |
| titleOfInvention |
Triblock peptide amphiphiles, micelles and methods of use |
| abstract |
One aspect of the present invention is directed to triblock peptides comprising a lipid moiety, a peptide block and a zwittenon-like block. Another aspect of the invention is directed to pharmaceutical compositions comprising the triblock peptides of the present in invention arranged in micelles in a pharmaceutically acceptable carrier. In certain embodiments, the pharmaceutical compositions of the present invention are vaccine compositions, which may further comprise an adjuvant. Another aspect of the invention is directed to methods of using the triblock peptides and compositions of the invention to treat a disease or condition. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023049791-A1 |
| priorityDate |
2017-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |